MedTrace Logo

Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)

NCT04427202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2024-12-12

Study results available
· View outcomes & findings →

Summary

This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.

Conditions

  • HIV
  • Hepatitis C
  • Opioid-use Disorder
  • Injection Drug Use

Interventions

BEHAVIORAL

Referral to harm reduction services

Participants are referred to harm reduction services

Sponsors & Collaborators

  • Southern Illinois University

    collaborator OTHER

  • Community Action Place, Inc.

    collaborator OTHER

  • New York University

    collaborator OTHER

  • University of Illinois at Chicago

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Mai Pho, PhD · University of Chicago

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-14
Primary Completion
2023-08-16
Completion
2023-08-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427202 on ClinicalTrials.gov